CAS 13146-72-0
:3'-désoxyinosine
- Inosine, 3'-deoxy-
- 3'-Deoxyinosine
Inosine, 3'-deoxy-
CAS :Formule :C10H12N4O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :252.22679-((2R,3R,5S)-3-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol
CAS :9-((2R,3R,5S)-3-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-olDegré de pureté :95%Masse moléculaire :252.23g/mol3'-Deoxy inosine
CAS :3'-Deoxy inosine is a Nucleoside Derivative - 3'-Modified nucleoside;3'-Deoxy nucleoside.Formule :C10H12N4O4Couleur et forme :SolidMasse moléculaire :252.23Ref: TM-TNU1498
5mgÀ demander10mgÀ demander25mgÀ demander50mgÀ demander100mgÀ demander500mgÀ demander3'-Deoxyinosine
CAS :Produit contrôléImpurity Didanosine EP Impurity D
Applications 3'-Deoxyinosine (Didanosine EP Impurity D) is an Inosine (I661000) analog with potential use as an antileishmanial drug. Used as an inhibiting agent in studies of Trypanosoma cruzi growth inside host cells in vitro. An impurity of the antiviral drug 2’,3’-Dideoxyinosine (D440950).
References Morishige, K. et al.: Exp. Parasitol., 80, 665 (1995); Aoki, T. et al.: Adv. Exp. Med. Biol., 370, 499 (1994);Formule :C10H12N4O4Couleur et forme :NeatMasse moléculaire :252.233'-Deoxyinosine
CAS :3'-Deoxyinosine is a nucleoside analog that is used in the treatment of leukemia, lymphoma, and AIDS-related Kaposi's sarcoma. The drug inhibits DNA synthesis by inhibiting enzymes such as ribonucleotide reductase, thymidylate synthase, and dihydrofolate reductase. 3'-Deoxyinosine has minimal toxicity and may be administered orally or intravenously. It has been shown to have an inhibitory effect on the growth of skin cancer cells and leishmania parasites in cell culture. This drug also lowers blood pressure by interfering with the synthesis of angiotensin II and may be useful for treating hypertension. The drug is synthetically prepared in a laboratory by chemists.
Formule :C10H12N4O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :252.23 g/mol





